Response
It has been nearly 2 decades since the observation was made that congenital complete heart block (CHB) is associated with maternal autoantibodies to SSA/Ro ribonucleoproteins 1,2 and, more recently, with SSB/La (Reference 2, review). A major consequence of these findings was to draw the attention of the rheumatology community to this fascinating problem of passively acquired autoimmunity. Through continued efforts of 2 newfound colleagues, the rheumatologist and cardiologist, there have been many important advances in this orphan disease. The target antigens and their genes are now well characterized, arrhythmogenic potential of the cognate autoantibodies has been identified, and animal models are being developed for study. [3] [4] [5] Indeed, study in this disease exemplifies bench-to-bedside research.
We are delighted to learn that our bench model of CHB has a human correlate. Our findings that direct administration of antibodies from mothers whose children have CHB to pregnant mice resulted in significant sinus bradycardia and firstdegree AV block in the pups focused the clinician's attention not only on the AV node but also on sinoatrial (SA) node conduction abnormalities. Accordingly, Dr Brucato's findings are of great interest and suggest that the spectrum of conduction abnormalities associated with maternal autoantibodies extend beyond the AV node. Although there is work to be done to define the true prevalence of sinus bradycardia in neonates of mothers with anti-SSA/Ro antibodies and to provide assurances that neonates of mothers with other autoantibodies are not similarly affected, the link to the animal model is promising. It remains a research challenge to identify the molecular mechanism by which a maternal antibody in the neonatal circulation affects the SA node. It is conceivable that maternal antibodies account for many fetal sinus bradycardias.
Our previous finding 3 demonstrating inhibition of Ca current in the human fetal ventricular myocyte by autoantibodies suggests that SA node Ca current and/or other pacemaker currents might also be affected and could contribute to the underlying mechanism of sinus bradycardia. This hypothesis is supported by our passive murine model, recently published. 4 
